🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Neuroendocrine Neoplasm

Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors NCT07536087NA1 site📍 Prague Institute for Clinical and Experimental Medicine · Tests: Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic lesions, Endoscopic ultrasound-guided radiof… A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 18F-DOPA II - PET Imaging Optimization NCT04706910Phase 31 site📍 Edmonton University of Alberta · Tests: 18F-DOPA, Furosemide Injection A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort NCT07808164n/a2 sites📍 Hanoi📍 Ho Chi Minh City Tam Anh Research Institute · Tests: IHC analysis for ENPP1, cGAS, and FAP expression A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites📍 Clovis📍 Los Angeles📍 Newport Beach Bristol-Myers Squibb · Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051n/a1 site📍 Austin Natera, Inc. Nutrition Intervention for Pancreatic Cancer NCT07554560NA2 sites📍 Philadelphia📍 Philadelphia Children's Hospital of Philadelphia · Tests: Structured Lipid Medical Food EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery NCT06519500n/a1 site📍 Rome Regina Elena Cancer Institute A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) NCT06505395Phase 21 site📍 Beijing CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Tests: SYHX2008 injection, Sandostatin LAR@ Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not NCT07273409NA4 sites📍 Gothenburg📍 Lund📍 Stockholm Uppsala University · Tests: Debulking surgery FTT PET/CT in Pancreatic Neuroendocrine Tumors NCT07114939Phase 11 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: [18F]FluorThanatrace Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors NCT06663072Phase 11 site📍 Chicago University of Chicago · Tests: Fulvestrant, 177Lu-DOTATATE Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders NCT00830557n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: medical chart review, survey administration, biospecimen collection 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site📍 Beijing Peking University Third Hospital · Tests: 68Ga-SorB PET/CT Pancreas Registry and High Risk Registry NCT02775461n/a2 sites📍 New York📍 New York Icahn School of Medicine at Mount Sinai Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites📍 Anderlecht📍 Ghent📍 Wilrijk European Organisation for Research and Treatment of Cancer … · Tests: Stereotactic body radiotherapy, Palliative RT Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms NCT05746182n/a3 sites📍 Los Angeles📍 San Diego📍 San Francisco University of California, San Francisco · Tests: Hereditary Cancer Panel MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors NCT05076760Phase 12 sites📍 Tampa📍 Durham Memgen, Inc. · Tests: MEM-288 Intratumoral Injection, Nivolumab, Docetaxel CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors NCT07429851n/a1 site📍 Milan European Institute of Oncology Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients NCT06893783Phase 24 sites📍 Seoul📍 Seoul📍 Seoul Inkeun Park · Tests: Tarlatamab A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) NCT07492680Phase 258 sites📍 San Francisco📍 Aurora📍 Atlanta Bristol-Myers Squibb · Tests: BMS-986504, Daraxonrasib, Nivolumab + Relatlimab FDC, Temozolomide, Pumitamig Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors NCT05847855n/a2 sites📍 Shanghai📍 Chengdu Fudan University · Tests: Blood collection INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) NCT07403630NA2 sites📍 Palermo📍 Perugia Azienda Ospedaliero-Universitaria di Parma · Tests: Functional tests, Multi-omics analyses, Cytogenetics/ FISH Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites📍 Duarte📍 Los Angeles📍 Stanford Anusha Kalbasi · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms NCT05243082NA1 site📍 Oslo Oslo University Hospital · Tests: Radio frequency ablation Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors NCT06596915Phase 11 site📍 Beijing Shandong Boan Biotechnology Co., Ltd · Tests: BA1302 Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients NCT03048266n/a1 site📍 Houston M.D. Anderson Cancer Center
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy